Medicine guide
Genvoya
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Elvitegravir;cobicistat;emtricitabine;tenofovir alafenamide
- Made by
- Gilead Sciences Ireland UC
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Genvoya is indicated for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus 1 (HIV 1) without any known mutations associated with resistance to the integrase inhibitor class, emtricitabine or tenofovir.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Gilead Sciences Ireland UC |
|---|---|
| Active substance | Elvitegravir;cobicistat;emtricitabine;tenofovir alafenamide |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J05AR · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2015-11-19 |
| Last updated by the regulator | 2026-05-08 |
| EMA product number | EMEA/H/C/004042 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).